About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Translational Lung Cancer Research
›
top-articles
Translational Lung Cancer Research
3.2
(top 10%)
impact factor
1.6K
(top 10%)
papers
24.7K
(top 10%)
citations
61
(top 10%)
h
-index
3.3
(top 10%)
impact factor
2.2K
all documents
28.1K
doc citations
101
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Non-small cell lung cancer: current treatment and future advances
Translational Lung Cancer Research
2016
1,256
2
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future
Translational Lung Cancer Research
2015
499
3
The epidemiology of lung cancer
Translational Lung Cancer Research
2018
488
4
Global trends of lung cancer mortality and smoking prevalence
Translational Lung Cancer Research
2015
306
5
Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities
Translational Lung Cancer Research
2015
303
6
Recurrence after surgery in patients with NSCLC
Translational Lung Cancer Research
2014
293
7
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review
Translational Lung Cancer Research
2015
241
8
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)
Translational Lung Cancer Research
2019
178
9
Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes
Translational Lung Cancer Research
2018
173
10
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Translational Lung Cancer Research
2015
173
11
Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance
Translational Lung Cancer Research
2016
166
12
Methods of measurement for tumor mutational burden in tumor tissue
Translational Lung Cancer Research
2018
166
13
Pros: Can tissue biopsy be replaced by liquid biopsy?
Translational Lung Cancer Research
2016
162
14
Current standards for clinical management of small cell lung cancer
Translational Lung Cancer Research
2018
161
15
Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians
Translational Lung Cancer Research
2018
152
16
Current state of immunotherapy for non-small cell lung cancer
Translational Lung Cancer Research
2007
150
17
Radiomics of pulmonary nodules and lung cancer
Translational Lung Cancer Research
2017
150
18
Epigenetics in non-small cell lung cancer: from basics to therapeutics
Translational Lung Cancer Research
2016
121
19
Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing
Translational Lung Cancer Research
2016
114
20
Treatment for small cell lung cancer, where are we now?-a review
Translational Lung Cancer Research
2016
110
21
Classification of pulmonary neuroendocrine tumors: new insights
Translational Lung Cancer Research
2017
104
22
Lung cancer in never smokers—the East Asian experience
Translational Lung Cancer Research
2018
104
23
Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer
Translational Lung Cancer Research
2015
103
24
Tobacco and the lung cancer epidemic in China
Translational Lung Cancer Research
2019
102
25
The clinical utility of tumor mutational burden in non-small cell lung cancer
Translational Lung Cancer Research
2018
98
26
Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis
Translational Lung Cancer Research
2017
97
27
Targeting DNA damage repair in small cell lung cancer and the biomarker landscape
Translational Lung Cancer Research
2018
96
28
The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials
Translational Lung Cancer Research
2019
95
29
Lung cancer prediction using machine learning and advanced imaging techniques
Translational Lung Cancer Research
2018
93
30
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
Translational Lung Cancer Research
2019
91
31
Cancer stem cells and immunoresistance: clinical implications and solutions
Translational Lung Cancer Research
2015
91
32
Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art
Translational Lung Cancer Research
2015
90
33
Small cell lung cancer (SCLC): no treatment advances in recent years
Translational Lung Cancer Research
2016
89
34
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients
Translational Lung Cancer Research
2016
88
35
Lung cancer molecular epidemiology in China: recent trends
Translational Lung Cancer Research
2014
87
36
Tobacco smoking after diagnosis of cancer: clinical aspects
Translational Lung Cancer Research
2019
85
37
Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)
Translational Lung Cancer Research
2015
85
38
Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?
Translational Lung Cancer Research
2013
84
39
The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Translational Lung Cancer Research
2016
80
40
Radiomics and artificial intelligence in lung cancer screening
Translational Lung Cancer Research
2021
80
41
Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring
Translational Lung Cancer Research
2016
79
42
Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted/banned asbestos use
Translational Lung Cancer Research
2020
79
43
Application of immunohistochemistry in diagnosis and management of malignant mesothelioma
Translational Lung Cancer Research
2020
77
44
Environmental and occupational determinants of lung cancer
Translational Lung Cancer Research
2019
76
45
Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression
Translational Lung Cancer Research
2019
75
46
Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms
Translational Lung Cancer Research
2019
74
47
Treatment of advanced squamous cell carcinoma of the lung: a review
Translational Lung Cancer Research
2015
74
48
The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention
Translational Lung Cancer Research
2015
73
49
Circulating tumor cells versus circulating tumor DNA in lung cancer—which one will win?
Translational Lung Cancer Research
2016
72
50
Angiogenesis in cancer: Anti-VEGF escape mechanisms
Translational Lung Cancer Research
2012
72
site/software ©
exaly
; All materials licenced under
CC by-SA
.